Global Bio-chem Technology Group Co Ltd (GBT) is a manufacturer and distributor of corn refined products and corn-based biochemical products. The company, along with its subsidiaries, undertakes the production and sale of corn refined products, amino acids, polyol chemicals, and corn sweeteners.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

GBT has been actively enhancing its research and development initiatives to strengthen its competitive position in the biochemical industry. The company is conducting phased testing for the resumption of production at the Xinglongshan site, which is positioned to serve as an incubation base for new products. This site is expected to introduce business alliances or capital investors to secure sufficient funding for the resumption of full production by stages, while enhancing its research and development facilities. The company plans to utilize the research centers and pilot testing facilities at the Xinglongshan site for the trial run production of high-value-added biochemical new products for future development. In the long run, the company aims to collaborate with various industry players, universities, and biochemical companies to further develop product lines suitable for more advanced applications. The company aims to maintain its market position by introducing new downstream products into commercial production and has completed several R&D projects on corn-based biochemical products. In FY2025, the company incurred expenses of HKD8.2 million on R&D, which as a percentage of revenue, stood at 0.4%.